Solid Biosciences (SLDB) Cash from Investing Activities (2017 - 2024)
Historic Cash from Investing Activities for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $38.6 million.
- Solid Biosciences' Cash from Investing Activities fell 1485.56% to $38.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$16.1 million, marking a year-over-year decrease of 26602.33%. This contributed to the annual value of -$16.1 million for FY2024, which is 26602.33% down from last year.
- Latest data reveals that Solid Biosciences reported Cash from Investing Activities of $38.6 million as of Q4 2024, which was down 1485.56% from -$11.0 million recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' Cash from Investing Activities peaked at $66.1 million during Q4 2022, and registered a low of -$72.5 million during Q3 2021.
- For the 5-year period, Solid Biosciences' Cash from Investing Activities averaged around -$1.6 million, with its median value being -$47500.0 (2020).
- In the last 5 years, Solid Biosciences' Cash from Investing Activities plummeted by 9053750.0% in 2021 and then soared by 10793714.29% in 2022.
- Solid Biosciences' Cash from Investing Activities (Quarter) stood at -$60000.0 in 2020, then soared by 50393.33% to $30.2 million in 2021, then soared by 119.05% to $66.1 million in 2022, then crashed by 31.47% to $45.3 million in 2023, then fell by 14.86% to $38.6 million in 2024.
- Its last three reported values are $38.6 million in Q4 2024, -$11.0 million for Q3 2024, and -$5.2 million during Q2 2024.